Riskpilot← Back to searchSign inGet full accessGYMO AS
ASActiveOrg 921549202Mekjarvik 14, 4072 RandabergWholesale of pharmaceutical and medical goods · NACE 4646Est. 20189 employees
Revenue 2024
NOK 55,7M
-7% vs 2023
EBITDA margin
10.9%
-57% vs 2023
Equity ratio
33.5%
Financial strength
Net profit 2024
NOK 4,6M
-57% vs 2023
| Revenue | NOK 55,7M | -7% |
| EBITDA | NOK 6,1M | -57% |
| Net profit | NOK 4,6M | -57% |
| Total assets | NOK 17,8M | -37% |
| Equity | NOK 6M | +3% |
| Employees | 9 | — |
Legal name
GYMO AS
Org number
921549202
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. oktober 2018
Share capital
NOK 60 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drive agenturhandel med medisinsk utstyr og helseartikler til helsevesenet.
Address
Mekjarvik 14, 4072 Randaberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 29 570 | 36 408 | 91 194 | 49 937 | 49 160 | 59 957 | 55 719 |
| Staff expenses | −3 602 | −4 550 | −5 807 | −6 282 | −6 391 | −6 509 | −8 129 |
| EBITDA | 5 783 | 6 982 | 35 898 | 8 410 | 8 641 | 14 076 | 6 101 |
| Depreciation & amort. | −107 | −63 | −26 | −30 | −81 | −129 | −142 |
| EBIT | 5 676 | 6 919 | 35 871 | 8 380 | 8 560 | 13 948 | 5 959 |
| Net financials | −219 | −544 | −1 201 | 34 | −86 | −222 | −79 |
| Profit before tax | 5 457 | 6 375 | 34 671 | 8 414 | 8 473 | 13 726 | 5 881 |
| Tax | 1 265 | 1 404 | 7 633 | 1 852 | 1 869 | 3 020 | 1 304 |
| Net profit | 4 192 | 4 971 | 27 038 | 6 562 | 6 605 | 10 706 | 4 577 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 10 481 | 13 393 | 40 951 | 20 578 | 19 329 | 28 182 | 17 773 |
| Equity | 6 026 | 8 297 | 27 135 | 6 065 | 6 081 | 5 758 | 5 955 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 455 | 5 096 | 13 816 | 14 512 | 13 248 | 22 424 | 11 818 |
| Total debt | 4 455 | 5 096 | 13 816 | 14 512 | 13 248 | 22 424 | 11 818 |
EBITDA margin
10.9%
This company
15.8%
Market median
-31% vs market
20182024
Equity ratio
33.5%
This company
38.2%
Market median
+12% vs market
20182024
Return on equity
76.9%
This company
18.4%
Market median
+318% vs market
20182024
Net profit margin
8.2%
This company
8.1%
Market median
+1% vs market
20182024
Asset turnover
3.13×
This company
1.12×
Market median
+179% vs market
20182024
Debt / equity
1.98×
This company
0.62×
Market median
-219% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MS Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Onemed As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Onemed As
GYMO AS Board members of GYMO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Svela | Chief Executive Officer | 0 companies |
| Jan Knoph | Chairman | 0 companies |
| Lars Peter Nilsson | Board of Directors | 0 companies |
| Robert Andrzej Kolakowski | Board of Directors | 0 companies |
| Jens Ole Ørneberg | Board of Directors | 0 companies |
| Cecilie Louise Buøen | Board of Directors | 0 companies |